Literature DB >> 17531163

Inclusion of high molecular weight dextran in calcium phosphate-mediated transfection significantly improves gene transfer efficiency.

C Wu1, Y Lu.   

Abstract

Calcium phosphate-based mammalian cell transfection is a widely used gene transfer technology. To facilitate the efficiency of this gene transfer method, several polysaccharide compounds were tested and evaluated for their effectiveness in enhancing DNA transfection. Using a HIV-1-derived lentivirus vector plasmid as a gene transfer indicator, we demonstrated that the addition of high molecular weight dextran-500 at 0.6-1.2% in the 2x Hepes buffered saline (HBS) increased transfection efficiency by over 50% (as reflected by the number of GFP-positive cells) and increased the titer of resulting lentivirus vector particles even more (up to 4-fold). This enhancement of transfection efficiency was further increased when higher molecular weight dextran formulations were used in place of dextran-500, and also when dextran was used in combination with polybrene, another polycationic chemical compound. Examination of transfected cells showed that dextran had no apparent adverse effect on cell viability and growth. Our data represent the first report showing that dextran can be used to enhance calcium phosphate-mediated gene transfer; this may be useful in applications for the generation of high-titer virus vector stocks using transient transfection technology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531163      PMCID: PMC2830788     

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  33 in total

1.  Stable suppression of gene expression by RNAi in mammalian cells.

Authors:  Patrick J Paddison; Amy A Caudy; Gregory J Hannon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

2.  Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells.

Authors:  Mary A Price; Scott S Case; Denise A Carbonaro; Xiao-Jin Yu; Denise Petersen; Kathleen M Sabo; Michael A Curran; Barbara C Engel; Hovanes Margarian; Janis L Abkowitz; Garry P Nolan; Donald B Kohn; Gay M Crooks
Journal:  Mol Ther       Date:  2002-11       Impact factor: 11.454

3.  Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors.

Authors:  Axel Heiser; Doris Coleman; Jens Dannull; Donna Yancey; Margaret A Maurice; Costas D Lallas; Philipp Dahm; Donna Niedzwiecki; Eli Gilboa; Johannes Vieweg
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

4.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.

Authors:  Nan Sook Lee; Taikoh Dohjima; Gerhard Bauer; Haitang Li; Ming-Jie Li; Ali Ehsani; Paul Salvaterra; John Rossi
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

6.  Involvement of ITF2 in the transcriptional regulation of melanogenic genes.

Authors:  M Furumura; S B Potterf; K Toyofuku; J Matsunaga; J Muller; V J Hearing
Journal:  J Biol Chem       Date:  2001-05-29       Impact factor: 5.157

7.  Enhanced plasmid DNA transfection with lysosomotropic agents in cultured fibroblasts.

Authors:  K Ciftci; R J Levy
Journal:  Int J Pharm       Date:  2001-05-07       Impact factor: 5.875

8.  High-yield production of recombinant antibody fragments in HEK-293 cells using sodium butyrate.

Authors:  Jürgen Grünberg; Karin Knogler; Robert Waibel; Ilse Novak-Hofer
Journal:  Biotechniques       Date:  2003-05       Impact factor: 1.993

9.  Alphavirus cDNA-based expression vectors: effects of RNA transcription and nuclear export.

Authors:  Marco Boorsma; Philippe Saudan; Holger Pfruender; James E Bailey; Sondra Schlesinger; Wolfgang A Renner; Marlin F Bachmann
Journal:  Biotechnol Bioeng       Date:  2003-03-05       Impact factor: 4.530

10.  Distribution of adenoviral vector in brain after intravenous administration.

Authors:  Chanil Moon; Cheil Moon; Wha-Sun Kang; Dae-Chul Jeong; Jong-Youl Jin
Journal:  J Korean Med Sci       Date:  2003-02       Impact factor: 2.153

View more
  11 in total

1.  Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells.

Authors:  Yuliia Kaljas; Chengqian Liu; Maksym Skaldin; Chengxiang Wu; Qing Zhou; Yuanan Lu; Ivona Aksentijevich; Andrey V Zavialov
Journal:  Cell Mol Life Sci       Date:  2016-09-23       Impact factor: 9.261

2.  Effective modifications for improved homologous recombination and high-efficiency generation of recombinant adenovirus-based vectors.

Authors:  Chengxiang Wu; Vivek R Nerurkar; Richard Yanagihara; Yuanan Lu
Journal:  J Virol Methods       Date:  2008-09-11       Impact factor: 2.014

3.  Klotho Deficiency Causes Heart Aging via Impairing the Nrf2-GR Pathway.

Authors:  Kai Chen; Shirley Wang; Qiwei Wilton Sun; Bo Zhang; Mujib Ullah; Zhongjie Sun
Journal:  Circ Res       Date:  2020-12-18       Impact factor: 17.367

4.  High-titre retroviral vector system for efficient gene delivery into human and mouse cells of haematopoietic and lymphocytic lineages.

Authors:  Chengxiang Wu; Yuanan Lu
Journal:  J Gen Virol       Date:  2010-04-21       Impact factor: 3.891

5.  Lentiviral vector-mediated stable expression of sTNFR-Fc in human macrophage and neuronal cells as a potential therapy for neuroAIDS.

Authors:  Shengbo Cao; Chengxiang Wu; Yongbo Yang; Lynn F Sniderhan; Sanjay B Maggirwar; Stephen Dewhurst; Yuanan Lu
Journal:  J Neuroinflammation       Date:  2011-05-14       Impact factor: 8.322

6.  Monocytes-derived macrophages mediated stable expression of human brain-derived neurotrophic factor, a novel therapeutic strategy for neuroAIDS.

Authors:  Jing Tong; Shilpa Buch; Honghong Yao; Chengxiang Wu; Hsin-I Tong; Youwei Wang; Yuanan Lu
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

7.  New insights into inhibition of human immunodeficiency virus type 1 replication through mutant tRNALys3.

Authors:  Chengxiang Wu; Vivek R Nerurkar; Yuanan Lu
Journal:  Retrovirology       Date:  2013-10-24       Impact factor: 4.602

8.  Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages.

Authors:  Wen Kang; Wayne A Marasco; Hsin-I Tong; Mary Margaret Byron; Chengxiang Wu; Yingli Shi; Si Sun; Yongtao Sun; Yuanan Lu
Journal:  J Neuroinflammation       Date:  2014-11-22       Impact factor: 8.322

9.  Monocyte Trafficking, Engraftment, and Delivery of Nanoparticles and an Exogenous Gene into the Acutely Inflamed Brain Tissue - Evaluations on Monocyte-Based Delivery System for the Central Nervous System.

Authors:  Hsin-I Tong; Wen Kang; Philip M C Davy; Yingli Shi; Si Sun; Richard C Allsopp; Yuanan Lu
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

10.  Application of ADA1 as a new marker enzyme in sandwich ELISA to study the effect of adenosine on activated monocytes.

Authors:  Chengqian Liu; Maksym Skaldin; Chengxiang Wu; Yuanan Lu; Andrey V Zavialov
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.